Q2 2022 Evofem Biosciences Inc Earnings Call Transcript
Good afternoon. Now I'll turn the call over to Amy Raskopf, Evofem Biosciences' Vice President of Investor Relations. Please go ahead.
Thank you, Larry. Good afternoon, everyone, and welcome to the Evofem Biosciences' Results Call for the Second Quarter of 2022. If you haven't done so already, I encourage you to access the presentation that accompanies this call and the press release we issued after market close, both of which may be found at evofem.com under the Investors tab.
Before we begin, I would like to remind you that remarks made on this call will contain forward-looking statements, which are made only as of today, August 4, 2022.
For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10-K and our most recently filed 10-Q. Also, we will discuss estimates and other statistical data made by independent parties and by company relating to the market size and growth and other data about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |